Coffee reduces the risk of hepatocellular carcinoma probably through inhibition of NLRP3 inflammasome activation by caffeine

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 12; p. 1029491
Main Author Fan, Frank S.
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 18.10.2022
Subjects
caffeine
coffee
hepatocellular carcinoma
NLRP3 inflammasome
Oncology
pyroptosis
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Federico Ravaioli, University of Bologna, Italy
ORCID: Frank S. Fan, orcid.org/0000-0002-8123-6941
This article was submitted to Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers, a section of the journal Frontiers in Oncology
Reviewed by: Xiaojie Gan, Naval Medical University, China
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2022.1029491